251 related articles for article (PubMed ID: 37625599)
1. Molecular imaging-guided extracellular vesicle-based drug delivery for precise cancer management: Current status and future perspectives.
Cheng Z; Shang J; Wang H; Yu L; Yuan Z; Zhang Y; Du Y; Tian J
J Control Release; 2023 Oct; 362():97-120. PubMed ID: 37625599
[TBL] [Abstract][Full Text] [Related]
2. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy.
Ma Y; Dong S; Li X; Kim BYS; Yang Z; Jiang W
Front Oncol; 2020; 10():606906. PubMed ID: 33628730
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification.
Liu Q; Li D; Pan X; Liang Y
J Nanobiotechnology; 2023 Sep; 21(1):334. PubMed ID: 37717008
[TBL] [Abstract][Full Text] [Related]
5. Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities.
Claridge B; Lozano J; Poh QH; Greening DW
Front Cell Dev Biol; 2021; 9():734720. PubMed ID: 34616741
[TBL] [Abstract][Full Text] [Related]
6. Engineered Extracellular Vesicles for Cancer Therapy.
Zhang X; Zhang H; Gu J; Zhang J; Shi H; Qian H; Wang D; Xu W; Pan J; Santos HA
Adv Mater; 2021 Apr; 33(14):e2005709. PubMed ID: 33644908
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicle- and Extracellular Vesicle Mimetics-Based Drug Delivery Systems: New Perspectives, Challenges, and Clinical Developments.
Gangadaran P; Ahn BC
Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32403320
[TBL] [Abstract][Full Text] [Related]
8. Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy.
Tang Y; Liu X; Sun M; Xiong S; Xiao N; Li J; He X; Xie J
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514088
[TBL] [Abstract][Full Text] [Related]
9. Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy.
Jayasinghe MK; Pirisinu M; Yang Y; Peng B; Pham TT; Lee CY; Tan M; Vu LT; Dang XT; Pham TC; Chen H; Leung AYH; Cho WC; Shi J; Le MT
Theranostics; 2022; 12(7):3288-3315. PubMed ID: 35547755
[TBL] [Abstract][Full Text] [Related]
10. Engineering strategies for customizing extracellular vesicle uptake in a therapeutic context.
Esmaeili A; Alini M; Baghaban Eslaminejad M; Hosseini S
Stem Cell Res Ther; 2022 Mar; 13(1):129. PubMed ID: 35346367
[TBL] [Abstract][Full Text] [Related]
11. Cellular Uptake of Engineered Extracellular Vesicles: Biomechanisms, Engineered Strategies, and Disease Treatment.
Xie Q; Hao Y; Li N; Song H; Chen X; Zhou Z; Wang J; Zhang Y; Li H; Han P; Wang X
Adv Healthc Mater; 2024 Jan; 13(2):e2302280. PubMed ID: 37812035
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
[TBL] [Abstract][Full Text] [Related]
14. Towards artificial intelligence-enabled extracellular vesicle precision drug delivery.
Greenberg ZF; Graim KS; He M
Adv Drug Deliv Rev; 2023 Aug; 199():114974. PubMed ID: 37356623
[TBL] [Abstract][Full Text] [Related]
15. Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy.
Sun Y; Sun F; Xu W; Qian H
Tissue Eng Regen Med; 2023 Apr; 20(2):157-175. PubMed ID: 36637750
[TBL] [Abstract][Full Text] [Related]
16. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
17. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles: Emerging tools as therapeutic agent carriers.
Liu S; Wu X; Chandra S; Lyon C; Ning B; Jiang L; Fan J; Hu TY
Acta Pharm Sin B; 2022 Oct; 12(10):3822-3842. PubMed ID: 36213541
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking.
Murphy DE; de Jong OG; Brouwer M; Wood MJ; Lavieu G; Schiffelers RM; Vader P
Exp Mol Med; 2019 Mar; 51(3):1-12. PubMed ID: 30872574
[TBL] [Abstract][Full Text] [Related]
20. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
Meng W; He C; Hao Y; Wang L; Li L; Zhu G
Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
